.On the heels of an FDA turndown for its chief rival Novo Nordisk, Eli Lilly is pushing on in the et...
.Only a few months after application the very first individual in a phase 2 test for recently identi...
.Eli Lilly's search for excessive weight aim ats has actually led it to the black genome. The Big Ph...
.Collection Biosciences is proceeding up. The tissue treatment provider has actually added $325 thou...
.After elevating $170 thousand back in February, metabolic disease-focused BioAge Labs has actually ...
.Aelis Farma's chances of getting a fast, positive decision on a $100 million choice remittance have...
.ProKidney has actually quit one of a pair of phase 3 tests for its own tissue treatment for renal c...
.Vaxcyte revealed what professionals referred to as "sensational" stage 1/2 data for its 31-valent p...
.Recursion has actually stumbled via a very early exam of its tech-enabled strategy to medication di...
.Contact it a scenario of good chemistry: Acepodia, a biotech based on Nobel Prize-winning scientifi...